Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
SU5402 attenuates LMP1-mediated aerobic glycolysis
male adult C57BL/6 mice) treatment induces rapid antidepressant effects in the social defeat stress model
The Missing Link between (Un)druggable and Degradable KRAS
2'-furan]-3
Acid red 88 is an anionic dye with potentially useful photocatalytic research applications
Nilotinib - CAS# 641571-10-0 Catalog No.:M10937-10 SU5402 attenuates LMP1-mediated aerobic glycolysisNilotinib, also known as AMN107, is a small molecule tyrosine kinase inhibitor approved for the treatment of imatinib resistant chronic myelogenous leukemia. Structurally related to imatinib, it was developed based on the structure of the Abl imatinib complex to address imatinib intolerance and resistance. Nilotinib is a selective Bcr Abl kinase inhibitor that is 10 30 fold more potent than imatinib in inhibiting Bcr Abl tyrosine kinase activity and